Hosted on MSN4d
CSL’s mixed half-year: plasma strength offsets vaccine weakness, bright outlook maintainedCSL (ASX:CSL) has posted its half-year results, delivering results that are best described as mixed. At the headline level, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback